Vachiramon Vasanop, Chaiyabutr Chayada, Rattanaumpawan Pinyo, Kanokrungsee Silada
Division of Dermatology, Faculty of Medicine Ramathibodi Hospital, Mahidol University, Bangkok, Thailand.
Department of Medicine, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand.
Lasers Surg Med. 2016 Feb;48(2):197-202. doi: 10.1002/lsm.22389. Epub 2015 Jul 14.
Conventional treatment of vitiligo on hands and feet often produces an unsatisfactory result. Various ablative treatment methods were tried with favorable results in facial, neck, and truncal areas. The aim of this study is to evaluate the efficacy and safety of combined fractional CO2 laser, narrowband UVB (NB-UVB) phototherapy, and topical clobetasol propionate in managing stable vitiligo in difficult-to-treat areas.
A prospective randomized-intraindividual study was conducted on 27 patients with 27 pair-lesions of non-segmental vitiligo on both hands. The lesions were randomized to receive treatment with fractional CO2 laser, NB-UVB phototherapy, and 0.05% clobetasol propionate cream (Group A) or NB-UVB phototherapy and 0.05% clobetasol propionate cream (Group B). Fractional CO2 laser was performed at 1-week interval for 10 sessions. NB-UVB phototherapy was administered twice weekly for 20 sessions. Patients were evaluated 12 weeks after the last treatment. Outcome was evaluated objectively based on standard digital photographs, patient satisfaction, and adverse events.
Twenty-six patients completed the study. Six vitiligious lesions (23.1%) in group A achieved good to excellent repigmentation compared with one lesion (3.9%) in group B (P = 0.065). The overall mean improvement score was 1.35 (± 1.38) in group A and 0.50 (± 0.95) in group B (P = 0.0004). Patients' satisfaction score was significantly higher for the lesions in group A than group B. Lesions on the dorsum of the hand showed a higher response rate than those on the fingers. No serious side-effects were noted.
This study demonstrates that adding fractional CO2 laser treatment to NB-UVB phototherapy and topical steroids improves the repigmentation rate of vitiliginous lesions on hands in some patients. This technique may be offered to vitiligo patients who are unresponsive to other treatments.
手部白癜风的传统治疗效果往往不尽人意。各种剥脱性治疗方法在面部、颈部和躯干部位取得了良好效果。本研究旨在评估联合分次二氧化碳激光、窄谱中波紫外线(NB-UVB)光疗及外用丙酸氯倍他索治疗难治性部位稳定期白癜风的疗效及安全性。
对27例双手患有27对非节段性白癜风皮损的患者进行前瞻性随机个体内研究。将皮损随机分为接受分次二氧化碳激光、NB-UVB光疗及0.05%丙酸氯倍他索乳膏治疗组(A组)或NB-UVB光疗及0.05%丙酸氯倍他索乳膏治疗组(B组)。分次二氧化碳激光每隔1周进行1次,共10次。NB-UVB光疗每周进行2次,共20次。在最后一次治疗后12周对患者进行评估。基于标准数码照片、患者满意度及不良事件对结果进行客观评估。
26例患者完成研究。A组6处白癜风皮损(23.1%)实现了良好至极佳的色素再生,而B组为1处皮损(3.9%)(P = 0.065)。A组总体平均改善评分为1.35(±1.38),B组为0.50(±0.95)(P = 0.0004)。A组皮损患者的满意度评分显著高于B组。手背皮损的反应率高于手指皮损。未观察到严重副作用。
本研究表明,在NB-UVB光疗和外用类固醇基础上加用分次二氧化碳激光治疗可提高部分手部白癜风皮损的色素再生率。该技术可应用于对其他治疗无反应的白癜风患者。